Hirofumi Shimada

1.2k citations
69 papers · 880 indexed · h-index 19

Hirofumi Shimada

62 papers receiving 866 citations

Peers

Hirofumi Shimada
Comparison fields: 5 of 89
  • Radiation 270
  • Pulmonary and Respiratory Medicine 558
  • Otorhinolaryngology 60
  • Rheumatology 156
  • Physical and Theoretical Chemistry 55
Replace Daisuke Maki with:
Daisuke Maki Japan
Shigeaki Ogura Japan
Peyman Kabolizadeh United States
Takeshi Hiraoka Japan
Dirk Böhmer Germany
D. M. Prescott United States
David A. Bush United States
J. Hasse Germany
J. Glaholm United Kingdom
John Armstrong Ireland
Hirofumi Shimada relative to Daisuke Maki Japan Daisuke Maki's profile →
Citations per field
00.5×11×
Daisuke Maki · 1×
Citations per year

Countries citing papers authored by Hirofumi Shimada

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Shimada more than expected).

Fields of papers citing papers by Hirofumi Shimada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Shimada. The network helps show where Hirofumi Shimada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hirofumi Shimada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hirofumi Shimada Line = papers co-authored together Hirofumi Shimada links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20222
2 20211
3 201725
4 20176
5 20176
6 20161
7 201626
8 20162
9 201537
10 20155
11 20157
12 20140
13 20147
14 201344
15 20113
16 201124
17 200541
18 20041
19 199912
20 19985

About Hirofumi Shimada

Hirofumi Shimada is a scholar working on Radiation, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 880 indexed citations. Recurring topics across this work include Radiation Therapy and Dosimetry (11 papers), Cerebrovascular and Carotid Artery Diseases (11 papers), Cancer Diagnosis and Treatment (10 papers), Advanced Radiotherapy Techniques (9 papers), Sarcoma Diagnosis and Treatment (9 papers), Intracranial Aneurysms: Treatment and Complications (7 papers), Radiation Detection and Scintillator Technologies (7 papers) and Bone Tumor Diagnosis and Treatments (7 papers). The work is most often cited by research in Radiation (270 citations), Pulmonary and Respiratory Medicine (558 citations) and Otorhinolaryngology (60 citations). Hirofumi Shimada has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Tatsuya Ohno, Setsuro Komiya, Takashi Nakano, Satoshi Nagano, Takao Setoguchi, Yasuhiro Ishidou, Masahiro Yokouchi, Hiromi Sasaki, Toshitada Yoshihara and Seiji Tobita. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026